Publication number: 20240425515
Abstract: Compound of the 7a,8,9,10,11,1la-hexahydro-1H,7H-pyrano[2,3-c]xanthene type, method of preparation thereof, intermediates thereof and therapeutic applications thereof. The present invention relates to compounds of formula (I) in which R0 represents O or N—ORa, R1 is OH or protected OH, R2 R3 R4 represent, independently, a C1-C4 alkyl, R5 represents OH, a protected OH, —O—P(?O)(OH)2, a sugar, H, a halogen, —CF3, a C1-C4 alkyl, a C2-C4 alkenyl or a C2-C4 alkynyl, R6 represents H, OH, protected OH, —O—P(?O)(OH)2, or a sugar, R7 represents H, OH, protected OH, a halogen, a C1-C4 alkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a triazolyl, —O—Rb, N(Rc)(Rd), —C(?O)—N(Re)(Rf), —O—C(?O)—N(Rg)(Rh), and R8, R9, R10, and R11 are, independently, H, OH or protected OH. The present invention further relates to the method of preparation thereof, the intermediates thereof and the therapeutic applications thereof.
Type:
Application
Filed:
July 4, 2022
Publication date:
December 26, 2024
Inventors:
Fanny ROUSSI, Sandy DESRAT, Gwenaëlle JEZEQUEL, Jérôme BIGNON, Marc LITAUDON, Bruno ANTONNY, Joëlle BIGAY, Bruno MESMIN